CURRENT OPINION IN BIOTECHNOLOGY

Current Opinion in Biotechnology (ISSN 0958-1669) is a prestigious, bimonthly peer-reviewed journal published by Elsevier in the United Kingdom, dedicated to disseminating authoritative reviews and critical perspectives on the latest advancements in biotechnology. As a high-impact publication indexed in the Science Citation Index (SCI), the journal consistently ranks within the first or second quartile of the Chinese Academy of Sciences (CAS) journal ranking system for biology and bioengineering, reflecting its strong academic reputation and influence in the field. The journal’s scope encompasses a wide array of interdisciplinary topics, including synthetic biology, bioengineering, environmental biotechnology, and food biotechnology, with a particular emphasis on providing readers with expert-driven insights into emerging trends and complex research challenges. Unlike traditional research journals that prioritize original experimental data, Current Opinion in Biotechnology focuses exclusively on high-quality, often invited, review articles that synthesize current knowledge and offer forward-looking analysis. This specialized format makes it an essential resource for researchers, educators, and industry professionals seeking to stay abreast of the state-of-the-art in biotechnology, while its rigorous editorial process and invitation-based submission model ensure that only the most significant and well-articulated contributions are published, thereby maintaining a high standard of scholarly discourse despite its non-open access model.